Patents by Inventor David W. Martin
David W. Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160207278Abstract: A scrim reinforced roofing membrane comprising a coated scrim layer having a first side and a second side and a first polyvinyl chloride layer on the first side of the coated scrim layer. The coated scrim layer contains a scrim fabric which contains a plurality of warp yarns in a first direction and a plurality of weft yarns in a second direction approximately perpendicular to the first direction. The warp yarns cross the weft yarns at crossing points. The scrim fabric has a polyvinyl acetate coating which is located along the length of the warp yarns and the weft yarns and between the warp and weft yarns at the crossing points. The coated scrim is at least partially embedded in the first polyvinyl chloride layer.Type: ApplicationFiled: December 17, 2015Publication date: July 21, 2016Inventors: David W. Martin, James D. Pinson
-
Patent number: 9374953Abstract: A grow plant enclosure to maximize plant density for a given growing area has a perimeter frame, a first pane, and a second pane. The first pane is adjacently connected to the perimeter frame, while the second pane is removably attached to the perimeter frame opposite the first pane to form a hollow enclosure. A plurality of plug holder openings traverses through the first pane, and optionally the second pane, being designed to receive a plurality of plant holders for growing various plant types. A plurality of supply tubes traverse into the perimeter frame through a plurality of supply tube openings and each have a plurality of spray nozzles to deliver nutrient solution to the root zone of the plants retained in the plurality of plant holders. Excess nutrient solution is released through a drain fixture positioned about the bottom of the perimeter frame.Type: GrantFiled: July 30, 2015Date of Patent: June 28, 2016Assignee: INDOOR FARMS OF AMERICA, LLCInventors: David W. Martin, Ronald R. Evans
-
Publication number: 20160159882Abstract: This application relates generally to the production of polypeptides having specific antigen-binding properties of Fv domains, for example, insertable variable fragments of antibodies, and modified ?1-?2 domains of NKG2D ligands.Type: ApplicationFiled: December 4, 2015Publication date: June 9, 2016Applicant: AvidBiotics Corp.Inventors: Kyle LANDGRAF, Daniel p. STEIGER, Steven R. WILLIAMS, David W. MARTIN
-
Publication number: 20160029578Abstract: A commercial plant cultivation system generates a controlled environment in which plants can be grown. A grow enclosure generate a controlled environment and can be either a mobile or fixed structure. A plurality of growing panels and a plurality of lighting fixtures are slidably mounted on a grow system support structure positioned within the grow enclosure. The plurality of growing panels can be positioned in either a vertical or horizontal configuration depending on the type of plants being grown. A nutrient delivery system is in fluid communication with the plurality of growing panels to deliver a nutrient solution to the plants. The nutrient solution is dispersed to the roots of the plants through a plurality of supply tubes positioned within each of the plurality of growing panels. Excess nutrient solution is collected and passed through a rock box in order to replenish nutrients and minerals.Type: ApplicationFiled: May 14, 2015Publication date: February 4, 2016Applicant: INDOOR FARMS OF AMERICA, LLCInventors: David W. Martin, Ronald R. Evans
-
Publication number: 20160029581Abstract: A grow plant enclosure to maximize plant density for a given growing area has a perimeter frame, a first pane, and a second pane. The first pane is adjacently connected to the perimeter frame, while the second pane is removably attached to the perimeter frame opposite the first pane to form a hollow enclosure. A plurality of plug holder openings traverses through the first pane, and optionally the second pane, being designed to receive a plurality of plant holders for growing various plant types. A plurality of supply tubes traverse into the perimeter frame through a plurality of supply tube openings and each have a plurality of spray nozzles to deliver nutrient solution to the root zone of the plants retained in the plurality of plant holders. Excess nutrient solution is released through a drain fixture positioned about the bottom of the perimeter frame.Type: ApplicationFiled: July 30, 2015Publication date: February 4, 2016Applicant: INDOOR FARMS OF AMERICA, LLCInventors: David W. Martin, Ronald R. Evans
-
Patent number: 9241453Abstract: A commercial plant cultivation system generates a controlled environment in which plants can be grown. A grow enclosure generate a controlled environment and can be either a mobile or fixed structure. A plurality of growing panels and a plurality of lighting fixtures are slidably mounted on a grow system support structure positioned within the grow enclosure. The plurality of growing panels can be positioned in either a vertical or horizontal configuration depending on the type of plants being grown. A nutrient delivery system is in fluid communication with the plurality of growing panels to deliver a nutrient solution to the plants. The nutrient solution is dispersed to the roots of the plants through a plurality of supply tubes positioned within each of the plurality of growing panels. Excess nutrient solution is collected and passed through a rock box in order to replenish nutrients and minerals.Type: GrantFiled: May 14, 2015Date of Patent: January 26, 2016Assignee: INDOOR FARMS OF AMERICA, LLCInventors: David W. Martin, Ronald R. Evans
-
Publication number: 20150316269Abstract: A method for modifying an open-top burner system to a radiant burner system involves providing a stovetop having an open top burner system which includes a grate, burner head, and a venturi burner. The venturi burner includes an open top annular channel about a central opening. Further provided are a central hole plug, an emitter, and a radiant burner head assembly. To modify the stovetop, the grate and burner head are removed from the stovetop and the central plug is used to block airflow through the central opening. The radiant burner head assembly is next positioned over the venturi burner and the emitter is positioned over the radiant burner head assembly. This series of steps thereby converts the assembly from a traditional open-top burner system to a radiant burner system. A kit may be provided to facilitate the process.Type: ApplicationFiled: July 10, 2015Publication date: November 5, 2015Inventors: Stanley E. DETTLOFF, David W. Martin
-
Patent number: 9109802Abstract: A method for modifying an open-top burner system to a radiant burner system involves providing a stovetop having an open top burner system which includes a grate, burner head, and a venturi burner. The venturi burner includes an open top annular channel about a central opening. Further provided are a central hole plug, an emitter, and a radiant burner head assembly. To modify the stovetop, the grate and burner head are removed from the stovetop and the central plug is used to block airflow through the central opening. The radiant burner head assembly is next positioned over the venturi burner and the emitter is positioned over the radiant burner head assembly. This series of steps thereby converts the assembly from a traditional open-top burner system to a radiant burner system. A kit may be provided to facilitate the process.Type: GrantFiled: May 29, 2012Date of Patent: August 18, 2015Inventors: Stanley E. Dettloff, David W. Martin
-
Patent number: 9079969Abstract: This invention describes soluble, monovalent, non-natural protein molecules that can activate NK cells and certain T-cells to attack specific cellular target cells by attaching the NKG2D-binding portions of monovalent MICA or MICB protein, i.e. their ?1-?2 platform domain, to the intended target cell specifically. The ?1-?2 domain is contiguous with a heterologous ?3 domain that has been genetically modified to bind directly or indirectly to the extracellular aspect of the target cell, thereby serving as the targeting domain. The genetic modification to create a non-natural and non-terminal targeting motif within the ?3 domain can include a portion of an antibody, another protein molecule or portion thereof, a peptide, or a non-natural, modified ?3 domain of a MIC protein.Type: GrantFiled: June 20, 2014Date of Patent: July 14, 2015Assignee: AvidBiotics Corp.Inventors: David W. Martin, Jr., Steven R. Williams
-
Publication number: 20150165065Abstract: This invention describes soluble, monovalent, non-natural protein molecules that can activate NK cells and certain T-cells to attack specific cellular target cells by attaching the NKG2D-binding portions of monovalent MICA or MICB protein, i.e. their ?1-?2 platform domain, to the intended target cell specifically. The ?1-?2 domain is contiguous with a heterologous ?3 domain that has been genetically modified to bind directly or indirectly to the extracellular aspect of the target cell, thereby serving as the targeting domain. The genetic modification to create a non-natural and non-terminal targeting motif within the ?3 domain can include a portion of an antibody, another protein molecule or portion thereof, a peptide, or a non-natural, modified ?3 domain of a MIC protein.Type: ApplicationFiled: December 5, 2014Publication date: June 18, 2015Applicant: AvidBiotics Corp.Inventors: Kyle LANDGRAF, Daniel P. Steiger, Steven R. Williams, David W. Martin, JR.
-
Patent number: 8929785Abstract: Flexible members for use in imaging devices contain a non-ionic surfactant and a fluorinated surfactant.Type: GrantFiled: September 24, 2013Date of Patent: January 6, 2015Assignee: Xerox CorporationInventors: Michael S Roetker, Francisco J Lopez, Kyle B Tallman, Jonathan H Herko, David W Martin, Yuhua Tong
-
Patent number: 8906513Abstract: The present teachings provide a fuser member. The fuser member includes a substrate layer comprising a polyamideimide/polybenzimidazole polymer blend. A method of manufacturing the fuser member is described.Type: GrantFiled: December 13, 2010Date of Patent: December 9, 2014Assignee: Xerox CorporationInventors: Jin Wu, Dante M. Pietrantoni, Yuhua Tong, David W. Martin
-
Patent number: 8906190Abstract: A system and apparatus are provided for adhering steering ribs to an intermediate transfer belt (ITB). These steering ribs (one or more) are applied to the ITB by placing the rib material around a cylindrical fixture. The rib material is held in place by a vacuum that is applied to the rib material to hold it against the fixture. An ITB may be separately held in place on the fixture by another vacuum until the rib material is adhered to the inside surface of the ITB through application of compressed air to force the rib material outward against the ITB. Once the rib material is adhered to the ITB, a series of apertures directs compressed air against the rib and the ITB to release them from the fixture.Type: GrantFiled: February 28, 2013Date of Patent: December 9, 2014Assignee: Xerox CorporationInventors: Jonathan H. Herko, David W. Martin, Scott J. Griffin, Michael S. Roetker, Dante M. Pietrantoni
-
Publication number: 20140302072Abstract: This invention describes soluble, monovalent, non-natural protein molecules that can activate NK cells and certain T-cells to attack specific cellular target cells by attaching the NKG2D-binding portions of monovalent MICA or MICB protein, i.e. their ?1-?2 platform domain, to the intended target cell specifically. The ?1-?2 domain is contiguous with a heterologous ?3 domain that has been genetically modified to bind directly or indirectly to the extracellular aspect of the target cell, thereby serving as the targeting domain. The genetic modification to create a non-natural and non-terminal targeting motif within the ?3 domain can include a portion of an antibody, another protein molecule or portion thereof, a peptide, or a non-natural, modified ?3 domain of a MIC protein.Type: ApplicationFiled: June 20, 2014Publication date: October 9, 2014Applicant: AvidBiotics Corp.Inventors: David W. MARTIN, JR., Steven R. Williams
-
Patent number: 8796420Abstract: This invention describes soluble, monovalent, non-natural protein molecules that can activate NK cells and certain T-cells to attack specific cellular target cells by attaching the NKG2D-binding portions of monovalent MICA or MICB protein, i.e. their ?1-?2 platform domain, to the intended target cell specifically. The ?1-?2 domain is contiguous with a heterologous ?3 domain that has been genetically modified to bind directly or indirectly to the extracellular aspect of the target cell, thereby serving as the targeting domain. The genetic modification to create a non-natural and non-terminal targeting motif within the ?3 domain can include a portion of an antibody, another protein molecule or portion thereof, a peptide, or a non-natural, modified ?3 domain of a MIC protein.Type: GrantFiled: July 5, 2011Date of Patent: August 5, 2014Assignee: AvidBiotics Corp.Inventors: David W. Martin, Jr., Steven R. Williams
-
Patent number: 8778503Abstract: An intermediate transfer member includes a poly(amic acid amideimide), or a mixture of a poly(amic acid amideimide), a phosphate ester, an optional polysiloxane, and an optional conductive filler component.Type: GrantFiled: March 29, 2011Date of Patent: July 15, 2014Assignee: Xerox CorporationInventors: Jin Wu, Jonathan H. Herko, Francisco J. Lopez, Kyle B. Tallman, Michael S. Roetker, David W. Martin, Brian P. Gilmartin
-
Patent number: 8716428Abstract: An fluorinated polyester compound is disclosed. The fluorinated polyester compound can be made by combining ingredients comprising a hydroxyl terminated polyphenyl ether; a carboxylic acid terminated perfluoropolyether; an acid catalyst; and a solvent. A coating solution comprising the fluorinated polyester compound and a method of coating a substrate therewith are also disclosed.Type: GrantFiled: April 10, 2012Date of Patent: May 6, 2014Assignee: Xerox CorporationInventors: Jin Wu, Lanhui Zhang, Lin Ma, David W. Martin
-
Patent number: 8673291Abstract: This disclosure relates to the discovery and isolation of the entire cluster of genes encoding R-type high molecular weight bacteriocins that specifically kill Clostridium difficile bacteria, dangerous human pathogens. Also disclosed are methods of producing the R-type bacteriocins in innocuous producer cells that, unlike C. difficile, do not die in the presence of oxygen. Disclosed also is the specific gene of the isolated gene cluster that determines the killing spectrum of the R-type bacteriocin and the demonstration that the killing spectra of diffocins can be altered by engineering orf1374 of the diffocin genetic locus. This invention offers a potent bactericidal agent and a means to make it in order to kill selectively C. difficile bacteria in the environment of the gastrointestinal tract where they can cause great harm and even death of the infected patient or farm animal.Type: GrantFiled: May 27, 2011Date of Patent: March 18, 2014Assignee: AvidBiotics Corp.Inventors: Dean M. Scholl, Dana M. Gebhart, Steven R. Williams, Gregory R. Govoni, David W. Martin, Jr.
-
Patent number: 8668976Abstract: There is described an intermediate transfer member comprising a seamless layer comprising a polyphenylsulfone and a polysiloxane having dispersed therein carbon black particles. The composition used to manufacture the seamless intermediate transfer member is also described.Type: GrantFiled: January 19, 2011Date of Patent: March 11, 2014Assignee: Xerox CorporationInventors: Jin Wu, Jonathan H. Herko, Francisco J. Lopez, Kyle B. Tallman, Dante M. Pietrantoni, David W. Martin, Yuhua Tong, Michael S. Roetker, Scott J. Griffin, Markus R. Silvestri
-
Patent number: 8658765Abstract: This invention describes soluble, monovalent, non-natural protein molecules that can activate NK cells and certain T-cells to attack specific cellular target cells by attaching the NKG2D-binding portions of monovalent MICA or MICB protein, i.e. their ?1-?2 platform domain, to the intended target cell specifically. The ?1-?2 domain is contiguous with a heterologous ?3 domain that has been genetically modified to bind directly or indirectly to the extracellular aspect of the target cell, thereby serving as the targeting domain. The genetic modification to create a non-natural and non-terminal targeting motif within the ?3 domain can include a portion of an antibody, another protein molecule or portion thereof, a peptide, or a non-natural, modified ?3 domain of a MIC protein.Type: GrantFiled: December 30, 2010Date of Patent: February 25, 2014Assignee: AvidBiotics Corp.Inventors: David W. Martin, Jr., Steven R. Williams